Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Key Switch in the Immune System Regulated by Splicing

12.04.2016

The protein MALT1 is an important switch in immune cells and affects their activity. Researchers at Helmholtz Zentrum München report in ‘Nature Communications’ that this activation is not always equally strong. Through alternative splicing, two variants of the protein may arise which have a stronger or weaker effect on the immune system. Understanding this process is important for the pharmacological use of MALT1.

The protein MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) controls the activation of lymphocytes and thus the immune response following bacterial or viral infections.


Isabel Meininger and Prof. Dr. Daniel Krappmann

Source: Helmholtz Zentrum München

For this purpose, the protease cleaves other proteins in the cell and is considered a potential target for the treatment of excessive immune responses as observed in autoimmune diseases (e.g. multiple sclerosis) or distinct malignant lymphomas.

To prevent an overshooting MALT1 activity, a team at the Research Unit Cellular Signal Integration (AZS) at Helmholtz Zentrum München is investigating which steps in this signaling chain are feasible for a pharmacological targeting. In the current study, the team led by Prof. Dr. Daniel Krappmann, head of the AZS Research Unit, focused on the two variants MALT1A and MALT1B, which arise through alternative splicing*.

Stronger activation of T cells

“To our surprise, we showed that MALT1 is regulated by posttranscriptional splicing,” said first author Isabel Meininger, a doctoral student at Helmholtz Zentrum München. “Depending on which MALT1 variant is expressed, the immune system activated is more or less,” she added.

Specifically, the scientists observed that MALT1A resulted in a stronger stimulation of T cells than MALT1B. According to the study, a molecule called hnRNP U (heterogeneous nuclear ribonucleoprotein U) regulates which of the two isoforms is preferably expressed. If it is present in only small amounts, higher levels of MALT1A are expressed, resulting in stronger activation of the T cells. However, if the quantity of hnRNP U is increased, higher levels of MALT1B are expressed and the response of the T cells is weaker.

“Our findings contribute to a better understanding of the function of MALT1 and enable us to better assess the potential impact of a pharmacological effect on this promising drug candidate,” said Krappmann. In previous studies he and his team already identified first pharmacological substances with which the function of MALT1 can be specifically altered. In future studies, the researchers want to confirm in a preclinical model the effects of MALT1 splicing on the immune system and the development of diseases.

Further Information

Background:
* Alternative splicing refers to a process in which a copy of a gene, the pre-mRNA, is spliced differently. Thus, several alternative RNA sequences can be generated that as a consequence lead to different proteins. In the case of MALT1 the variants A and B differ only through the presence of a short sequence that encodes eleven amino acids. If this region is missing, as in the case of MALT1B, this leads to an impaired ability to stimulate T cells.

Original Publication:
Meininger, I. et al. (2016). Alternative splicing of MALT1 controls signaling and activation of CD4+ T cells, Nature Communications, DOI: 10.1038/NCOMMS11292

The Helmholtz Zentrum München, the German Research Center for Environmental Health, pursues the goal of developing personalized medical approaches to the prevention and therapy of major common diseases such as diabetes and lung disease. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. It is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. The Helmholtz Zentrum München is a partner in the German Center for Diabetes Research. http://www.helmholtz-muenchen.de/en/index.html

The Research Unit Cellular Signal Integration (AZS) at the Institute of Molecular Toxicology and Pharmacology conducts research for a better understanding of cellular communication. In doing so, it focuses on the interaction of protein complexes and the effects of posttranslational modifications. The aim of this research is to elucidate the faulty regulation of the signaling chains in the immune system, which may contribute to the development of infectious diseases, lymphoma and autoimmune diseases, and to modulate these processes pharmacologically. http://www.helmholtz-muenchen.de/en/azs/index.html

Scientific contact at Helmholtz Zentrum München
Prof. Dr. Daniel Krappmann, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Research Unit Cellular Signal Integration, Ingolstädter Landstr. 1, 85764 Neuherberg - Tel.: +49 89 3187-3461, E-mail: daniel.krappmann@helmholtz-muenchen.de

Sonja Opitz | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

Further reports about: Cellular Helmholtz Protein Signal T cells autoimmune diseases diseases immune system

More articles from Materials Sciences:

nachricht Watching atoms move in hybrid perovskite crystals reveals clues to improving solar cells
22.11.2017 | University of California - San Diego

nachricht Fine felted nanotubes: CAU research team develops new composite material made of carbon nanotubes
22.11.2017 | Christian-Albrechts-Universität zu Kiel

All articles from Materials Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

UCLA engineers use deep learning to reconstruct holograms and improve optical microscopy

22.11.2017 | Medical Engineering

Watching atoms move in hybrid perovskite crystals reveals clues to improving solar cells

22.11.2017 | Materials Sciences

New study points the way to therapy for rare cancer that targets the young

22.11.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>